Experience at Son Espases University Hospital with daratumumab, bortezomib, lenalidomide and dexamethasone (D-VRd) as first line treatment in multiple myeloma-MedSci.cn

Experience at Son Espases University Hospital with daratumumab, bortezomib, lenalidomide and dexamethasone (D-VRd) as first line treatment in multiple myeloma

Monsonis, LP; Sampalo, MG; Montana, AP; Raga, JMS; Mayol, AS

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S122

科室
- - 订阅+
  - 更多科室
工具
服务